How is it different from semaglutide?

Tirzepatide acts on two receptors, GLP-1 and GIP, rather than one. Each person responds differently to each treatment, and your provider will review your history to advise which is more appropriate for you.

How long until I see results?

Appetite changes are usually noticed in the first one to two weeks. More noticeable weight changes typically appear between the second and fourth month.

Do I need a strict diet?

No. The treatment reduces appetite naturally. Your provider may recommend dietary adjustments, but no specific diet is required.

Treatment

Tirzepatide Injections

A weekly compounded tirzepatide injection, with dual action on GLP-1 and GIP.

From $359/mo

Start your evaluation

How this treatment works

Tirzepatide acts on two hormone receptors, GLP-1 and GIP, which are involved in regulating appetite, glucose, and metabolism, while semaglutide acts on GLP-1 alone. It is given once a week as a subcutaneous injection, with a gradual dose increase.

What's included

Medical evaluation with a US-licensed provider
A treatment plan personalized to your health history
Medication shipped to your home in discreet packaging
Syringes, needles, and an injection kit
Medical follow-up throughout the program
The full PesoBUENO^™ program, at no additional cost

Side effects and considerations

Nausea, most common while the dose is being increased
Constipation or diarrhea
Mild fatigue during the first weeks
Marked appetite reduction — expected, but watch your hydration

This list is not exhaustive. Your doctor will review your full medical history during the evaluation.

Questions about this treatment

Treatment subject to medical review. Available only for adults 18+ in states where telehealth is permitted for this medication.

SaludBUENO guarantee
Free, fast shipping
Doctor-led plans & follow-up
No hidden fees

hola@saludbueno.com 877.283.6624 - 877.BUENO24 5224 W. State Road 46, PMB #358, Sanford, FL 32771

The evaluation available on the SaludBUENO website does not by itself establish a provider-patient relationship between the person completing it and SaludBUENO. CareValidate, a network of U.S.-licensed providers that follows protocols designed for patient safety, sets exclusionary criteria to determine whether a person does not qualify for GLPs treatments. The answers you submit determine whether your case is eligible for review. If you qualify, a licensed provider will review your case before any prescription.

All claims and benefits described on this site are based on experiences reported by patients enrolled in programs that include compounded medications and consultations with health professionals. Results may vary and depend on multiple factors, including program adherence and the treating provider's recommendations.

Compounded GLP medications are produced in FDA-regulated 503A pharmacies. Although these facilities are highly regulated, compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded medications is based on the licensed provider's clinical judgment, taking into account the telehealth consultation and the patient's medical history.

We encourage anyone interested in compounded medications to consult with a health professional about the specific risks and benefits. SaludBUENO does not produce compounded medications. The product received may look different from the images shown on this site.